<--- Back to Details
First PageDocument Content
Medicine / Chemistry / Immunosuppressants / Treprostinil / Clevidipine / Fabry disease / Health / Alpha-galactosidase
Medicine
Chemistry
Immunosuppressants
Treprostinil
Clevidipine
Fabry disease
Health
Alpha-galactosidase

Agalsidase beta, Fabrazyme, Genzyme Corp

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 38,54 KB

Share Document on Facebook

Similar Documents

Medicine / Health care / Intensive care medicine / Clinical medicine / Medical specialties / Stress hyperglycemia / Clevidipine / Intensive care unit / Anesthesiologist / Intensivist / Intensive insulinotherapy / Diabetes management

A m e r i c a n S o c i e t y Volume 20 Number 2 o f C r i t i c a l

DocID: 1r1uf - View Document

Treatment of Acute Postoperative Hypertension in Cardiac Surgery Patients: An Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery-2 (ESCAPE-2), a Randomized, Double-Blind,

DocID: 1bkxR - View Document

Biology / Neuropathic pain / Lidocaine / Treprostinil / Clevidipine / Chemistry / Organic chemistry / Medicine

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use UNITUXIN safely and effectively. See Full Prescribing Information for UNITUXIN. -------------------------------CONT

DocID: 197El - View Document

Organochlorides / Nitrazepam / Clinical trial / Clevidipine / Axitinib / Chemistry / Organic chemistry / Lactams

 Venous thrombotic events (VTE) have been observed, including fatal pulmonary emboli (PE). Monitor for signs and symptoms of VTE and PE. (5.6)  Gastrointestinal perforation or fistula has occurred. Fatal perforat

DocID: 18INW - View Document

Phenols / Organochlorides / Hypertension / Medical emergencies / Hypertensive emergency / Phentolamine / Clevidipine / Antihypertensive drug / Fenoldopam / Medicine / Chemistry / Organic chemistry

1 FERNE / EMRA Resident Forum 2010 Hypertensive Emergencies Case Conference Optimal Management

DocID: 14O7F - View Document